STIM vs. KRMD, ALUR, BLUA, TELA, BWAY, NVNO, DCTH, MGRM, PDEX, and SRTS
Should you be buying Neuronetics stock or one of its competitors? The main competitors of Neuronetics include KORU Medical Systems (KRMD), Allurion Technologies (ALUR), BlueRiver Acquisition (BLUA), TELA Bio (TELA), BrainsWay (BWAY), enVVeno Medical (NVNO), Delcath Systems (DCTH), Monogram Orthopaedics (MGRM), Pro-Dex (PDEX), and Sensus Healthcare (SRTS). These companies are all part of the "surgical & medical instruments" industry.
Neuronetics (NASDAQ:STIM) and KORU Medical Systems (NASDAQ:KRMD) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, institutional ownership, profitability, analyst recommendations, dividends, community ranking, valuation, earnings and risk.
KORU Medical Systems has lower revenue, but higher earnings than Neuronetics. KORU Medical Systems is trading at a lower price-to-earnings ratio than Neuronetics, indicating that it is currently the more affordable of the two stocks.
Neuronetics has a beta of 2.5, meaning that its stock price is 150% more volatile than the S&P 500. Comparatively, KORU Medical Systems has a beta of 0.55, meaning that its stock price is 45% less volatile than the S&P 500.
53.6% of Neuronetics shares are owned by institutional investors. Comparatively, 58.6% of KORU Medical Systems shares are owned by institutional investors. 9.8% of Neuronetics shares are owned by insiders. Comparatively, 25.6% of KORU Medical Systems shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.
Neuronetics has a net margin of -42.31% compared to KORU Medical Systems' net margin of -45.24%. KORU Medical Systems' return on equity of -25.10% beat Neuronetics' return on equity.
Neuronetics presently has a consensus price target of $8.00, indicating a potential upside of 109.97%. KORU Medical Systems has a consensus price target of $3.50, indicating a potential upside of 50.86%. Given Neuronetics' higher probable upside, research analysts plainly believe Neuronetics is more favorable than KORU Medical Systems.
In the previous week, KORU Medical Systems had 4 more articles in the media than Neuronetics. MarketBeat recorded 8 mentions for KORU Medical Systems and 4 mentions for Neuronetics. Neuronetics' average media sentiment score of 0.46 beat KORU Medical Systems' score of 0.44 indicating that Neuronetics is being referred to more favorably in the media.
Neuronetics received 89 more outperform votes than KORU Medical Systems when rated by MarketBeat users. Likewise, 68.31% of users gave Neuronetics an outperform vote while only 60.00% of users gave KORU Medical Systems an outperform vote.
Summary
KORU Medical Systems beats Neuronetics on 10 of the 18 factors compared between the two stocks.
Get Neuronetics News Delivered to You Automatically
Sign up to receive the latest news and ratings for STIM and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding STIM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Neuronetics Competitors List
Related Companies and Tools
